Top cardiology stories of January: The battle against heart disease, marijuana use in CVD and more
Click Here to Manage Email Alerts
Healio and Cardiology Today present the top-read articles published in January 2020. Healio readers were most interested in the impact of green tea on ASCVD, contributors to losing the battle against heart disease, the ability of positive ECG and negative echocardiography to identify patients with elevated CV risk, the use of marijuana in patients with CVD and more.
Green tea may lower risk for ASCVD, mortality in Chinese population
Habitual drinking of tea, particularly green tea, confers a significant reduction in risk for atherosclerotic CVD and all-cause mortality, according to research published in the European Journal of Preventive Cardiology. Read more
Losing the battle against heart disease
Any clinician who has been working in medicine for more than a decade knows that the practice of medicine has really changed, and how clinicians are forced to practice medicine today may have contributed to the decline in patient outcomes that we’re currently seeing. Read more
Positive ECG, negative echocardiography may identify patients with elevated cardiac risk
Patients with positive ECG results and normal stress echocardiography had a slightly increased risk for adverse cardiac events, according to a study published in JAMA Internal Medicine. Read more
Vital exhaustion may increase AF risk
Patients who reported vital exhaustion on a questionnaire had an increased risk for incident atrial fibrillation, according to a study published in the European Journal of Preventive Cardiology. Read more
BP elevations occur earlier in life for women vs. men
BP elevations occurred more rapidly in women compared with men and as early as the third decade of life, which may explain why CVD presents at different times between both sexes, according to a study published in JAMA Cardiology. Read more
STRENGTH CV outcomes trial of omega-3 fatty acid stopped for futility
AstraZeneca announced that it will close the STRENGTH CV outcomes trial of omega-3 carboxylic acids in patients with mixed dyslipidemia at high risk for CVD. Read more
More than 2 million patients with CVD have reported marijuana use
Despite the modest strength of current evidence, cardiologists should screen and test their patients for marijuana use in select CV settings, according to a review published in the Journal of the American College of Cardiology. Read more
In AF, obstructive sleep apnea confers stroke risk
Among patients with atrial fibrillation, obstructive sleep apnea was an independent risk factor for major adverse CV and neurologic events, particularly stroke, according to findings published in the American Heart Journal. Read more
New use for an old drug: The potential of colchicine in CVD
Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after recent presentations of the COLCOT and COLCHICINE-PCI trials at the American Heart Association Scientific Sessions in November. Read more
AHA aims to increase healthy life expectancy by 2030
As the number of deaths from CVD and stroke continues to decline, albeit at a slower rate than before, the American Heart Association is striving to increase healthy life expectancy both in the United States and globally, according to a presidential advisory, a statistical update and a policy statement prepared by the organization and published in Circulation. Read more